Construction and validation of a nomogram based on N6-Methylandenosine-related lncRNAs for predicting the prognosis of non-small cell lung cancer patients.
Cancer medicine（2023）
摘要
Our study demonstrated that m ARLncSig could act as a potential biomarker for evaluating the prognosis and therapeutic efficacy in NSCLC patients.
更多查看译文
关键词
N6-methyladenosine,long non-coding RNAs,non-small cell lung cancer,prognostic signature
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要